AG
PTLA

Advisor Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Advisor Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$203K Sell
8,546
-2,127
-20% -$58.7K ﹤0.01% 2383
2019
Q3 		$287K Buy
10,673
+1,371
+15% +$38.5K ﹤0.01% 2047
2019
Q2 		$252K Buy
9,302
+681
+8% +$21.4K ﹤0.01% 2126
2019
Q1 		$299K Buy
8,621
+3,305
+62% +$95.4K ﹤0.01% 1974
2018
Q4 		$105K Sell
5,316
-788
-13% -$16.2K ﹤0.01% 2618
2018
Q3 		$163K Buy
6,104
+1,246
+26% +$40.7K ﹤0.01% 2351
2018
Q2 		$183K Buy
4,858
+508
+12% +$19.4K ﹤0.01% 2045
2018
Q1 		$143K Sell
4,350
-639
-13% -$28K ﹤0.01% 2253
2017
Q4 		$243K Buy
4,989
+858
+21% +$43.4K ﹤0.01% 1838
2017
Q3 		$223K Sell
4,131
-2,369
-36% -$139K ﹤0.01% 1776
2017
Q2 		$365K Sell
6,500
-1,600
-20% -$64.1K 0.01% 1347
2017
Q1 		$317K Sell
8,100
-550
-6% -$17.5K 0.01% 1354
2016
Q4 		$194K Sell
8,650
-300
-3% -$5.86K ﹤0.01% 1571
2016
Q3 		$204K Buy
8,950
+6,202
+226% +$146K ﹤0.01% 1508
2016
Q2 		$63K Buy
+2,748
New +$67.8K ﹤0.01% 2247

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Advisor Group's PTLA Position: Q4 2019 in Review

Advisor Group reduced its Portola Pharmaceuticals, Inc. (PTLA) stake by 20% in Q4 2019, selling an estimated $58.7K and leaving 8,546 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Advisor Group first reported a position in PTLA in Q2 2016 and has held it in 15 quarters since. The position peaked at $365K in Q2 2017. 224 funds tracked by Wall St. Rank hold PTLA as of Q4 2019.

  • Advisor Group held 8,546 shares of Portola Pharmaceuticals, Inc. worth $203K as of Q4 2019.
  • Advisor Group sold 2,127 Portola Pharmaceuticals, Inc. shares in Q4 2019, an estimated $58.7K.
  • Portola Pharmaceuticals, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2383 holding.
  • Advisor Group first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Portola Pharmaceuticals, Inc. position peaked at $365K in Q2 2017.
  • 224 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.